These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9485038)

  • 1. Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells.
    Lamm GM; Christofori G
    Cancer Res; 1998 Feb; 58(4):801-7. PubMed ID: 9485038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An insulin-like growth factor-mediated, phosphatidylinositol 3' kinase-independent survival signaling pathway in beta tumor cells.
    Burtscher I; Compagni A; Lamm GM; Christofori G
    Cancer Res; 1999 Aug; 59(16):3923-6. PubMed ID: 10463584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.
    Christofori G; Naik P; Hanahan D
    Nature; 1994 Jun; 369(6479):414-8. PubMed ID: 7910953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines.
    Alexia C; Lasfer M; Groyer A
    Ann N Y Acad Sci; 2004 Dec; 1030():219-29. PubMed ID: 15659801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
    Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A
    Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinoma.
    Zumsteg A; Caviezel C; Pisarsky L; Strittmatter K; García-Echeverría C; Hofmann F; Christofori G
    Mol Cancer Res; 2012 Jun; 10(6):800-9. PubMed ID: 22562956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factors induce apoptosis as well as proliferation in LIM 1215 colon cancer cells.
    Fu P; Thompson JA; Leeding KS; Bach LA
    J Cell Biochem; 2007 Jan; 100(1):58-68. PubMed ID: 16888814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor activity and induction of insulin-like growth factor-1-resistant apoptosis by SC-alphaalphadelta9.
    Vogt A; Wang AS; Johnson CS; Fabisiak JP; Wipf P; Lazo JS
    J Pharmacol Exp Ther; 2000 Feb; 292(2):530-7. PubMed ID: 10640289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Fas ligand does not confer immune privilege to a pancreatic beta tumor cell line (betaTC-3).
    Okamoto S; Takamizawa S; Bishop W; Wen J; Kimura K; Sandler A
    J Surg Res; 1999 Jun; 84(1):77-81. PubMed ID: 10334893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II.
    Lund P; Schubert D; Niketeghad F; Schirmacher P
    Cancer Lett; 2004 Mar; 206(1):85-96. PubMed ID: 15019164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trophic support promotes survival of bcl-x-deficient telencephalic cells in vitro.
    Shindler KS; Yunker AM; Cahn R; Zha J; Korsmeyer SJ; Roth KA
    Cell Death Differ; 1998 Oct; 5(10):901-10. PubMed ID: 10203689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.
    Remacle-Bonnet MM; Garrouste FL; Heller S; André F; Marvaldi JL; Pommier GJ
    Cancer Res; 2000 Apr; 60(7):2007-17. PubMed ID: 10766192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
    Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
    Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.
    Di Popolo A; Memoli A; Apicella A; Tuccillo C; di Palma A; Ricchi P; Acquaviva AM; Zarrilli R
    Oncogene; 2000 Nov; 19(48):5517-24. PubMed ID: 11114729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
    Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
    Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-II induces CREB phosphorylation and cell survival in human lung cancer cells.
    Linnerth NM; Baldwin M; Campbell C; Brown M; McGowan H; Moorehead RA
    Oncogene; 2005 Nov; 24(49):7310-9. PubMed ID: 16158061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.